Won Kim

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Sequential use of the androgen synthesis inhibitors ketoconazole and abiraterone acetate in castration-resistant prostate cancer and the predictive value of circulating androgens
    Won Kim
    Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California
    Clin Cancer Res 20:6269-76. 2014
  2. ncbi Androgen receptor directed therapies in castration-resistant metastatic prostate cancer
    Won Kim
    Genitourinary Medical Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, CA 94115, USA
    Curr Treat Options Oncol 13:189-200. 2012

Detail Information

Publications2

  1. ncbi Sequential use of the androgen synthesis inhibitors ketoconazole and abiraterone acetate in castration-resistant prostate cancer and the predictive value of circulating androgens
    Won Kim
    Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California
    Clin Cancer Res 20:6269-76. 2014
    ..The purpose of this study was to determine the clinical utility of abiraterone and its impact on circulating androgens following ketoconazole...
  2. ncbi Androgen receptor directed therapies in castration-resistant metastatic prostate cancer
    Won Kim
    Genitourinary Medical Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, CA 94115, USA
    Curr Treat Options Oncol 13:189-200. 2012
    ..In this review, the rationale for and clinical results with these new therapies will be discussed as will the future directions required to fully leverage these therapeutic modalities to the maximum clinical benefit for patients...